Dangerous bacterial biofilms have a natural enemy
Scientists have discovered a plant-produced chemical that inhibits bacterial biofilm formation, offering potential benefits for healthcare and industrial equipment corrosion prevention. …
Red light exposure linked to lowered risk of blood clots
New findings suggest that exposure to long-wavelength red light lowers the risk of blood clots, highlighting the potential of light therapy to reduce cardiovascular risk. …
Immunocompromised individuals may not produce enough RSV antibodies after vaccination
Individuals aged 60 and older with weakened immunity, especially organ transplant recipients on immunosuppressive drugs and those with immune disorders, have a weaker response to RSV vaccines. …
New migraine pill may provide instant relief
Data from three phase 3 clinical trials on the safety and effectiveness of the migraine drug atogepant show that it acts quickly to prevent migraines. …
Potential vaccine target for colorectal and urinary tract cancers identified in bacteria
New findings suggest that targeting two strains of colibactin-producing bacteria with treatments or vaccines could help reduce the risk of colorectal and urinary tract cancers. …
Tirzepatide shows powerful diabetes-prevention effect in three-year trial
Tirzepatide, a new injectable weight-loss drug, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period compared to a placebo. …
How doxycycline for STI prevention affects the gut microbiome
Researchers used metagenomic sequencing to study the effects of doxycycline post-exposure prophylaxis (Doxy-PEP) for sexually transmitted infections (STIs) on the gut microbiome and antibiotic resistance. …
Cancer prevention: How an aging immune system fuels cancer growth
New preclinical model suggests blocking inflammation pathways may reverse cancer-promoting effects of aging, inspiring early-phase clinical drug trials. …
Single blood test predicts 30-year cardiovascular disease risks for women
Measuring two types of fat in the bloodstream along with C-reactive protein (CRP), a marker of inflammation, can predict a woman’s risk for cardiovascular disease decades later. …
Candidate malaria vaccine provides lasting protection in NIH-sponsored trials
Two randomized, double-blind, placebo-controlled trials of an experimental malaria vaccine found that the vaccine was safe and effective for healthy adults and women of childbearing age. …
End of content
End of content
